Current Pharmacological Treatment Approaches to Central Nervous System Leukaemia
- 1 May 1991
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 41 (5) , 702-716
- https://doi.org/10.2165/00003495-199141050-00003
Abstract
Significant advances in the treatment and prevention of meningeal leukaemia have been made in the past 3 decades. This progress has resulted from the development of innovative approaches to treatment...Keywords
This publication has 49 references indexed in Scilit:
- Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1989
- Central Nervous System Pharmacology of Antileukemic DrugsJournal of Pediatric Hematology/Oncology, 1989
- PHARMACOLOGY AND TOXICITY OF HIGH-DOSE CYTARABINE BY 72-HOUR CONTINUOUS INFUSION1986
- Central nervous system toxicity of high-dose cytosine arabinoside.1985
- Central nervous system pharmacokinetics of high-dose cytosine arabinosideJournal of Neuro-Oncology, 1985
- Remission induction of meningeal leukemia with high-dose intravenous methotrexate.Journal of Clinical Oncology, 1985
- PHASE-II AND PHARMACOKINETIC STUDY OF AZIRIDINYLBENZOQUINONE [2,5-DIAZIRIDINYL-3,6-BIS(CARBOETHOXYAMINO)-1,4-BENZOQUINONE, DIAZIQUONE, NSC-182986] IN HIGH-GRADE GLIOMAS1983
- The central nervous system in childhood leukemia: I. The arachnoidCancer, 1973
- The influence of previous lumbar puncture and pneumoencephalography on the incidence of unsuccessful radioisotope cisternography.1971
- The increasing incidence of central nervous system leukemia in children.(Children's cancer study group a)Cancer, 1970